Masimo EPS - Earnings per Share 2007-2018 | MASI
Masimo annual and quarterly earnings per share history from 2007 to 2018. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Masimo EPS for the quarter ending December 31, 2018 was $0.82, a 685.71% decline year-over-year.
- Masimo EPS for the twelve months ending December 31, 2018 was $3.45, a 54.71% increase year-over-year.
- Masimo 2018 annual EPS was $3.45, a 54.71% increase from 2017.
- Masimo 2017 annual EPS was $2.23, a 61.88% decline from 2016.
- Masimo 2016 annual EPS was $5.85, a 277.42% increase from 2015.
| Masimo Annual EPS | |
|---|---|
| 2018 | $3.45 |
| 2017 | $2.23 |
| 2016 | $5.85 |
| 2015 | $1.55 |
| 2014 | $1.30 |
| 2013 | $1.02 |
| 2012 | $1.07 |
| 2011 | $1.05 |
| 2010 | $1.21 |
| 2009 | $0.88 |
| 2008 | $0.53 |
| 2007 | $0.60 |
| 2006 | $3.04 |
| 2005 | $0.42 |
| Masimo Quarterly EPS | |
|---|---|
| Q4 2018 | $0.82 |
| Q3 2018 | $1.02 |
| Q2 2018 | $0.79 |
| Q1 2018 | $0.82 |
| Q4 2017 | $-0.14 |
| Q3 2017 | $0.64 |
| Q2 2017 | $0.80 |
| Q1 2017 | $0.93 |
| Q4 2016 | $4.23 |
| Q3 2016 | $0.52 |
| Q2 2016 | $0.57 |
| Q1 2016 | $0.53 |
| Q4 2015 | $0.45 |
| Q3 2015 | $0.36 |
| Q2 2015 | $0.36 |
| Q1 2015 | $0.38 |
| Q4 2014 | $0.40 |
| Q3 2014 | $0.27 |
| Q2 2014 | $0.24 |
| Q1 2014 | $0.39 |
| Q4 2013 | $0.17 |
| Q3 2013 | $0.27 |
| Q2 2013 | $0.30 |
| Q1 2013 | $0.28 |
| Q4 2012 | $0.26 |
| Q3 2012 | $0.24 |
| Q2 2012 | $0.30 |
| Q1 2012 | $0.27 |
| Q4 2011 | $0.23 |
| Q3 2011 | $0.24 |
| Q2 2011 | $0.28 |
| Q1 2011 | $0.30 |
| Q4 2010 | $0.26 |
| Q3 2010 | $0.27 |
| Q2 2010 | $0.24 |
| Q1 2010 | $0.44 |
| Q4 2009 | $0.22 |
| Q3 2009 | $0.22 |
| Q2 2009 | $0.22 |
| Q1 2009 | $0.22 |
| Q4 2008 | $-0.02 |
| Q3 2008 | $0.22 |
| Q2 2008 | $0.18 |
| Q1 2008 | $0.15 |
| Q4 2007 | $0.20 |
| Q3 2007 | $0.16 |
| Q2 2007 | $0.13 |
| Q1 2007 | $0.11 |
| Q3 2006 | $0.16 |
| Q2 2006 | $0.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.532B | $0.858B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $103.653B | 23.36 |
| Intuitive Surgical (ISRG) | United States | $60.918B | 56.18 |
| Edwards Lifesciences (EW) | United States | $36.879B | 37.71 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.161B | 16.54 |
| IDEXX Laboratories (IDXX) | United States | $18.800B | 51.17 |
| Teleflex (TFX) | United States | $12.764B | 27.96 |
| Hologic (HOLX) | United States | $12.643B | 19.12 |
| Varian Medical Systems (VAR) | United States | $11.872B | 29.66 |
| ABIOMED (ABMD) | United States | $11.567B | 76.36 |
| STERIS (STE) | United Kingdom | $10.390B | 26.70 |
| DexCom (DXCM) | United States | $10.286B | 394.10 |
| Penumbra (PEN) | United States | $4.469B | 252.88 |
| Integra LifeSciences Holdings (IART) | United States | $4.364B | 21.13 |
| Globus Medical (GMED) | United States | $4.343B | 26.36 |
| Wright Medical Group (WMGI) | Netherlands | $3.499B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.234B | 19.94 |
| Tandem Diabetes Care (TNDM) | United States | $3.156B | 0.00 |
| Cantel Medical (CMD) | United States | $2.694B | 26.80 |
| Glaukos (GKOS) | United States | $2.528B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.313B | 18.80 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.999B | 21.71 |
| Nevro (NVRO) | United States | $1.997B | 0.00 |
| Inogen (INGN) | United States | $1.726B | 34.21 |
| OPKO Health (OPK) | United States | $1.479B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.116B | 0.00 |
| SILK RD MEDICAL (SILK) | United States | $1.027B | 0.00 |
| CryoLife (CRY) | United States | $1.022B | 110.20 |
| Accelerate Diagnostics (AXDX) | United States | $1.019B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.001B | 27.22 |
| Luminex (LMNX) | United States | $0.988B | 44.84 |
| Veracyte (VCYT) | United States | $0.947B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.908B | 172.43 |
| Intersect ENT (XENT) | United States | $0.895B | 0.00 |
| Fluidigm (FLDM) | United States | $0.885B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.862B | 35.27 |
| Natus Medical (BABY) | United States | $0.816B | 16.93 |
| AxoGen (AXGN) | United States | $0.812B | 0.00 |
| Shockwave Medical (SWAV) | United States | $0.810B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.753B | 26.27 |
| ViewRay (VRAY) | United States | $0.678B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.534B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.533B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.422B | 44.06 |
| GenMark Diagnostics (GNMK) | United States | $0.399B | 0.00 |
| Si-Bone (SIBN) | United States | $0.368B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.362B | 44.73 |
| Accuray (ARAY) | United States | $0.360B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.323B | 0.00 |
| IRadimed (IRMD) | United States | $0.287B | 60.67 |
| Neuronetics (STIM) | United States | $0.284B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.248B | 0.00 |
| Sientra (SIEN) | United States | $0.220B | 0.00 |
| ConforMIS (CFMS) | United States | $0.182B | 0.00 |
| SOLITON INC (SOLY) | $0.174B | 0.00 | |
| Nuvectra (NVTR) | United States | $0.173B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.143B | 0.00 |
| EDAP TMS (EDAP) | France | $0.137B | 474.00 |
| Biosig Technologies (BSGM) | United States | $0.128B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.126B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.114B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.112B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 0.00 |
| Vermillion (VRML) | United States | $0.100B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.078B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.074B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.068B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.051B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.049B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| PAVmed (PAVM) | United States | $0.032B | 0.00 |
| Avinger (AVGR) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.026B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.025B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.025B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.023B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.021B | 67.67 |
| Dynatronics (DYNT) | United States | $0.017B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.016B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.011B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| Presbia (LENS) | Ireland | $0.010B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
